SHANGHAI JUNSHI BIOSCIENCESSHANGHAI JUNSHI BIOSCIENCESSHANGHAI JUNSHI BIOSCIENCES

SHANGHAI JUNSHI BIOSCIENCES

No trades
See on Supercharts

688180 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Shanghai Junshi Biosciences Co., Ltd. engages in the discovery, development, clinical research, and commercialization of biopharmaceutical drugs. Its products include toripalimab injection, UBP1211, JS002, and UBP1213. The company was founded by Zhuo Bing Zhang and Ji Kuan Shan on December 27, 2012 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

688180 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company